Prothena | Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Acadia Pharmaceuticals USD 44.6M 4.38M 2025-09
Agios Pharmaceuticals USD -103.43M 8.59M 2025-09
Akebia Therapeutics USD 6.11M 28.92M 2025-03
ALKERMES USD 100.74M 4.1M 2025-09
Alnylam Pharmaceuticals USD 238.97M 274.33M 2025-09
Amgen USD 3.92B 2.35B 2025-09
Biogen USD 557.3M 186.7M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Exelixis USD 252.69M 275K 2025-12
Immunic USD -21.38M 8.2M 2024-06
Incyte USD 482.31M 75.7M 2025-09
Ionis Pharmaceuticals USD -129M 253M 2025-09
MacroGenics USD 16.82M 52.97M 2025-09
Nektar Therapeutics USD -37.05M 15.27M 2024-09
Neurocrine Biosciences USD 291.8M 132.3M 2025-09
Prothena USD -36.91M 44.05M 2025-09
Regeneron Pharmaceuticals USD 1.76B 244.6M 2025-09
Ultragenyx Pharmaceutical USD -179.54M 65.54M 2025-09
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09
Xoma USD 15.98M 24.58M 2024-06


Prothena Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.